Azathioprine: an Update on Clinical Efficacy and Safety in Inflammatory Bowel Disease

Background: The approval of azathioprine (AZA) for the long-term therapy of patients with Crohn's disease in The Netherlands. Methods: Review and update of the literature on clinical efficacy and safety of AZA in inflammatory bowel disease. Results: AZA and its metabolite 6-mercaptopurine (6-MP...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Scandinavian journal of gastroenterology 1999, Vol.34 (230), p.111-115
Hauptverfasser:	Lamers, C B, Griffioen, G, van Hogezand, R A, Veenendaal, R A
Format:	Artikel
Sprache:	eng
Schlagworte:	Azathioprine - therapeutic use Humans Immunosuppressive Agents - therapeutic use Inflammatory Bowel Diseases - drug therapy Remission Induction - methods Safety Secondary Prevention Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!